{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:04:01Z","timestamp":1791353041874,"version":"4.3.1"},"reference-count":161,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jneuroim.2010.09.015","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T07:53:16Z","timestamp":1289289196000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies"],"prefix":"10.1016","volume":"231","author":[{"given":"Helmar C.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.09.015_bb0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","article-title":"Acute conduction block in vitro following exposure to antiganglioside sera","volume":"16","author":"Arasaki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-510X(98)00283-4","article-title":"The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro","volume":"161","author":"Arasaki","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis","volume":"4","author":"Asbury","year":"1969","journal-title":"Medicine"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0020","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/iai.62.5.2122-2125.1994","article-title":"Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure","volume":"62","author":"Aspinall","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S0317167100028894","article-title":"Neuropathy with onion bulb formations and pure motor manifestations","volume":"16","author":"Auer","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/WNL.44.3_Part_1.429","article-title":"Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study","volume":"44","author":"Azulay","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.61.4.362","article-title":"Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"61","author":"Ben-Smith","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(95)12155-2","article-title":"Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice","volume":"201","author":"Buchwald","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ana.410440610","article-title":"Neuromuscular blockade by IgG antibodies from patients with Guillain-Barre syndrome: a macro-patch-clamp study","volume":"44","author":"Buchwald","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1460-9568.1998.00053.x","article-title":"Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals","volume":"10","author":"Buchwald","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.10205","article-title":"Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barre syndrome","volume":"51","author":"Buchwald","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","article-title":"Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barre syndrome","volume":"68","author":"Creange","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jnnp.64.2.162","article-title":"Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function","volume":"64","author":"Creange","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-5728(02)00430-7","article-title":"Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcgammaRII expression in patients with chronic inflammatory neuropathies","volume":"135","author":"Creange","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-5728(90)90048-R","article-title":"Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease","volume":"30","author":"Dau","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-5728(95)00121-4","article-title":"Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis","volume":"62","author":"Dau","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(98)00266-5","article-title":"Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy","volume":"95","author":"De Luca","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Diener","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0750","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mus.21433","article-title":"Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee","volume":"40","author":"Donofrio","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410340208","article-title":"The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders","volume":"34","author":"Enders","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0120","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/jnnp.57.9.1118","article-title":"Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome","volume":"57","author":"Exley","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0125","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids","volume":"22","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","volume":"41","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1537-2995.1983.23584018711.x","article-title":"Alterations of lymphocyte responsiveness in Guillain-Barre syndrome. Effects of plasma exchange","volume":"23","author":"Glassman","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","article-title":"Drug insight: the use of intravenous immunoglobulin in neurology\u2014therapeutic considerations and practical issues","volume":"3","author":"Gold","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0150","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0155","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1523\/JNEUROSCI.4279-04.2005","article-title":"Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy","volume":"25","author":"Goodfellow","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0160","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1526-0968.2001.00386.x","article-title":"Plasmapheresis affects T helper type-1\/T helper type-2 balance of circulating peripheral lymphocytes","volume":"5","author":"Goto","year":"2001","journal-title":"Ther. Apher."},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2010.09.015_bb0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor-sensory axonal Guillain-Barre syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0175","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barre syndrome","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.jneuroim.2010.09.015_bb0190","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0195","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ana.410310416","article-title":"Motor nerve biopsy in severe Guillain-Barre syndrome","volume":"31","author":"Hall","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0205","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh231","article-title":"Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy","volume":"127","author":"Halstead","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.20546","article-title":"Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome","volume":"58","author":"Halstead","year":"2005","journal-title":"Ann. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.jneuroim.2010.09.015_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-3002-0","article-title":"Advances in the understanding of the mechanism of action of IVIg","volume":"255","author":"Hartung","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-510X(99)00190-2","article-title":"Antibody responses in the Guillain-Barre syndrome","volume":"168","author":"Hartung","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"Suppl","key":"10.1016\/j.jneuroim.2010.09.015_bb0225","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ana.410270716","article-title":"T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"27","author":"Hartung","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-5728(92)90134-7","article-title":"Inflammatory mediators in demyelinating disorders of the CNS and PNS","volume":"40","author":"Hartung","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Immunopathogenesis and treatment of the Guillain-Barre syndrome\u2014part I","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2010.09.015_bb0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-3083.1985.tb01868.x","article-title":"In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis","volume":"22","author":"Holmdahl","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0260","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0265","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barre syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0770","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"6","author":"Hughes","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0280","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.164.8.4375","article-title":"Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy","volume":"164","author":"Ill\u00e9s","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0285","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.braindev.2004.02.012","article-title":"Acute dysautonomia: complete recovery after two courses of IVIg","volume":"26","author":"Ishitobi","year":"2004","journal-title":"Brain Dev."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0755","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/157015909790031166","article-title":"Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies","volume":"7","author":"Jacob","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0295","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awg235","article-title":"Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding","volume":"126","author":"Jacobs","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0300","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.410330204","article-title":"Pathological findings at the site of conduction block in multifocal motor neuropathy","volume":"33","author":"Kaji","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0305","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1526-0968.2002.00466.x","article-title":"Miller Fisher syndrome and plasmapheresis","volume":"6","author":"Kambara","year":"2002","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0310","series-title":"A Practical Guide to Therapeutic Plasma Exchange","author":"Kaplan","year":"1999"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.1990.181","article-title":"Plasma exchange with a rotating filter","volume":"38","author":"Kaplan","year":"1990","journal-title":"Kidney Int."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0325","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.69.3.362","article-title":"Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies","volume":"69","author":"Kiefer","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0330","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0340","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.wco.0000245365.51823.72","article-title":"Immune circuitry in the peripheral nervous system","volume":"19","author":"Kieseier","year":"2006","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0345","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.wco.0000245364.51823.3b","article-title":"The inflamed peripheral nervous system: update on immune therapies","volume":"19","author":"Kieseier","year":"2006","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0350","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating neuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0760","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","article-title":"Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr\u00e9 syndrome","volume":"66","author":"Kuitwaard","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410330304","article-title":"Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues","volume":"33","author":"Kuroki","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0765","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archneurol.2010.105","article-title":"IGIV-C CIDP Efficacy (ICE) Study Group, 2010. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"67","author":"Latov","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study","volume":"124","author":"L\u00e9ger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0365","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archneur.63.7.930","article-title":"Plasma exchange in neuroimmunological disorders. Part 1: rationale and treatment of central nervous system disorders","volume":"63","author":"Lehmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0370","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.63.8.1066","article-title":"Plasma exchange in neuroimmunological disorders. Part 2: treatment of neuromuscular disorders","volume":"63","author":"Lehmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/nen.0b013e3180408daa","article-title":"Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies","volume":"66","author":"Lehmann","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model","volume":"27","author":"Lehmann","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1756285609104792","article-title":"Pathogenesis and treatment of immune-mediated neuropathies","volume":"2","author":"Lehmann","year":"2009","journal-title":"Ther. Adv. Neurol. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archneurol.2009.331","article-title":"Autoantibody-mediated dysfunction of sympathetic neurons in Guillain-Barre syndrome","volume":"67","author":"Lehmann","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0395","doi-asserted-by":"crossref","unstructured":"Lehmann, H.C., Hoffmann, F.R., Fusshoeller, A., Hetzel, G.R., Hartung, H.P., Schroeter, M., Kieseier, B., 2008. The therapeutic value of plasma exchange in multifocal motor neuropathy. J. Neurol. Sci. 271, 34\u201339.","DOI":"10.1016\/j.jns.2008.02.022"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0400","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(02)00139-X","article-title":"High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies","volume":"128","author":"Lopez","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0405","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/awn074","article-title":"Structural requirements of anti-GD1a antibodies determine their target specificity","volume":"131","author":"Lopez","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.73.3.320","article-title":"Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Mahad","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0415","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","article-title":"Immune responses to myelin proteins in Guillain-Barre syndrome","volume":"79","author":"Makowska","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410390121","article-title":"Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen","volume":"39","author":"Malik","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0425","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.51.2.394","article-title":"Nerve biopsy in children with severe Guillain-Barre syndrome and inexcitable motor nerves","volume":"51","author":"Massaro","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0430","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1468-1331.2007.01929.x","article-title":"Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies","volume":"14","author":"Mat\u00e0","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(99)00009-X","article-title":"TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies","volume":"163","author":"Mathey","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0440","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11882-007-0041-z","article-title":"Plasmapheresis for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"7","author":"Mehndiratta","year":"2007","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0445","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2004.10.001","article-title":"Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF","volume":"228","author":"Mei","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0450","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0455","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneuro0452","article-title":"From bench to bedside\u2014experimental rationale for immune-specific therapies in the inflamed peripheral nerve","volume":"3","author":"Meyer zu Horste","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0460","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/WNL.56.5.666","article-title":"Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"56","author":"Misawa","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0465","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0470","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(01)00266-1","article-title":"Multifocal motor neuropathy","volume":"115","author":"Nobile-Orazio","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0475","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00019052-200410000-00010","article-title":"IgM paraproteinaemic neuropathies","volume":"17","author":"Nobile-Orazio","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0780","doi-asserted-by":"crossref","unstructured":"Nobile-Orazio, E., Gallia, F., Tuccillo, F., Terenghi, F., 2010. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update. 23, 519\u2013523.","DOI":"10.1097\/WCO.0b013e32833dd218"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0480","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp.61.6.649","article-title":"Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides","volume":"61","author":"O'Leary","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0485","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.wco.0000173284.25581.2f","article-title":"Recent developments in Miller Fisher syndrome and related disorders","volume":"18","author":"Overell","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0785","article-title":"Recent developments in Miller Fisher syndrome and related disorders","author":"Piepers","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0490","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0495","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2004.09.020","article-title":"Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"159","author":"Press","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0505","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/jama.1969.03150210065008","article-title":"Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barre syndrome","volume":"207","author":"Ramos-Alvarez","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0510","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/00003246-199910000-00003","article-title":"Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group","volume":"27","author":"Reeves","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0515","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barr\u00e9 syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0520","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.2008.159798","article-title":"Humoral and cellular immune responses to myelin protein peptides in Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume":"80","author":"Sanvito","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0525","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0530","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0535","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.52.9.1833","article-title":"I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome","volume":"52","author":"Sharief","year":"1999","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2010.09.015_bb0540","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerves","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0545","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ana.20173","article-title":"An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice","volume":"56","author":"Sheikh","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0550","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.68.4.533","article-title":"Plasmapheresis in multifocal motor neuropathy: a case report","volume":"68","author":"Specht","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0555","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0560","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0790","doi-asserted-by":"crossref","unstructured":"Tackenberg, B., Nimmerjahn, F., L\u00fcnemann, J.D., 2010. Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy. J. Clin. Immunol. 30 (Suppl. 1), S65\u2013S69.","DOI":"10.1007\/s10875-010-9398-1"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0565","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-5728(89)90095-7","article-title":"T lymphocyte activation antigens in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy","volume":"24","author":"Taylor","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0570","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnen\/63.2.129","article-title":"Multifocal motor neuropathy: pathologic alterations at the site of conduction block","volume":"63","author":"Taylor","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0800","doi-asserted-by":"crossref","unstructured":"Tracy, J.A., Dyck, P.J., 2010. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies. Curr. Opin. Neurol. 23, 242\u2013248.","DOI":"10.1097\/WCO.0b013e3283394203"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0575","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-1331.2006.01521.x","article-title":"Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulins","volume":"13","author":"Trebst","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0580","first-page":"449","article-title":"Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study","volume":"48","author":"Tsokos","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0585","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(05)70074-0","article-title":"Multifocal motor neuropathy","volume":"4","author":"Van Asseldonk","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0590","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp.2005.064816","article-title":"Axon loss is an important determinant of weakness in multifocal motor neuropathy","volume":"77","author":"van Asseldonk","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0595","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(94)00185-Q","article-title":"Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases","volume":"58","author":"Van den Berg","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0600","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jnnp.63.5.674","article-title":"Intravenous immunoglobulin treatment in lower motor neuron disease associated with highly raised anti-GM1 antibodies","volume":"63","author":"van den Berg","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0605","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. The Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.jneuroim.2010.09.015_bb0775","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10875-010-9408-3","article-title":"Intravenous immunoglobulin treatment in multifocal motor neuropathy","volume":"30","author":"van der Pol","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0610","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.40.2.209","article-title":"High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study","volume":"40","author":"van Doorn","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0615","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.jneuroim.2010.09.015_bb0805","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s10875-010-9407-4","article-title":"IVIG treatment and prognosis in Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0620","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study","volume":"56","author":"Vermeulen","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0625","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1750-3639.2001.tb00407.x","article-title":"Paraproteinemic neuropathies","volume":"11","author":"Vital","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0630","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barre syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0635","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0640","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","article-title":"Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside","volume":"56","author":"Willison","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0645","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150200072","article-title":"Gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy","volume":"249","author":"Winer","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0650","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0655","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000008227","article-title":"Lymphocyte subset proportions in Guillain-Barre syndrome patients treated with plasmapheresis","volume":"44","author":"Yoshii","year":"2000","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0660","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coi.2005.09.004","article-title":"Carbohydrate mimicry: a new paradigm of autoimmune diseases","volume":"17","author":"Yuki","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0665","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0022-510X(96)00053-6","article-title":"Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies","volume":"139","author":"Yuki","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0670","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0675","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2220\/biomedres.13.451","article-title":"Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barre syndrome: molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni","volume":"13","author":"Yuki","year":"1992","journal-title":"Biomed. Res."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0680","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mus.880150806","article-title":"Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies","volume":"15","author":"Yuki","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0685","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mus.880160610","article-title":"Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome","volume":"16","author":"Yuki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0690","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ana.410360517","article-title":"Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome","volume":"36","author":"Yuki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0695","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.51.3.875","article-title":"Minimal number of plasma exchanges needed to reduce immunoglobulin in Guillain-Barre syndrome","volume":"51","author":"Yuki","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0700","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0705","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0795","doi-asserted-by":"crossref","unstructured":"Yuki, N., Watanabe, H., Nakajima, T., Sp\u00e4th, P.J., 2010. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry (Electronic publication ahead of print).","DOI":"10.1136\/jnnp.2010.205856"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0710","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0961203309106921","article-title":"Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside","volume":"18","author":"Zandman-Goddard","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0715","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1096\/fj.03-0199fje","article-title":"Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease","volume":"17","author":"Zehntner","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0720","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/brain\/awh127","article-title":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies","volume":"127","author":"Zhang","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0725","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneuroim.2005.12.001","article-title":"Comparison of different brands of IVIg in an in vitro model of immune neuropathy","volume":"173","author":"Zhang","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0730","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.1994.tb06142.x","article-title":"Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis","volume":"98","author":"Zhu","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0735","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0740","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-5728(01)00255-7","article-title":"Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade enhances incidence and severity of experimental autoimmune neuritis in resistant mice","volume":"115","author":"Zhu","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.015_bb0745","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00241-7","article-title":"CD28-B7 costimulation: a critical role for initiation and development of experimental autoimmune neuritis in C57BL\/6 mice","volume":"114","author":"Zhu","year":"2001","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:15:21Z","timestamp":1759047321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810004340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":161,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0165572810004340"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.015","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma exchange and intravenous immunoglobulins: Mechanism of action in immune-mediated neuropathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}